DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nifedipine (Nifedipine) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nifedipine disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Nifedipine side effects in male

Reported by a consumer/non-health professional from United States on 2012-02-09

Patient: male, weighing 91.6 kg (201.6 pounds)

Reactions: Pruritus, Skin Exfoliation, Haemorrhage, Scab, Psoriasis, Oropharyngeal Pain, Hemiparesis, Myalgia, Visual Impairment

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Avapro
    Dosage: 300mg daily oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-10-14
    End date: 2009-03-12

Nifedipine
    Dosage: 60mg day daily oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2005-12-01
    End date: 2009-04-13



Possible Nifedipine side effects in 81 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-10

Patient: 81 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Encephalopathy, Disorientation

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Sorafenib (Raf Kinase Inhibitor)
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2010-05-14
    End date: 2010-08-23

Sorafenib (Raf Kinase Inhibitor)
    Administration route: Oral
    Start date: 2010-08-27
    End date: 2010-09-29

Nifedipine
    Dosage: 10 mg, qd
    Indication: Hypertension
    Start date: 2009-06-01
    End date: 2010-08-23

Nifedipine
    Dosage: 10 mg (daily dose), qd,



Possible Nifedipine side effects in female

Reported by a health professional (non-physician/pharmacist) from Portugal on 2011-12-13

Patient: female

Reactions: Visual Impairment, Tachycardia, Drug Interaction, Headache, Tremor, Loss of Consciousness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cosopt
    Indication: Intraocular Pressure Increased

Nifedipine
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2011-11-16
    End date: 2011-11-16

Other drugs received by patient: Influenza Virus A Whole Virion Vaccine Inactivated (H1n1); Ciprofibrate; Hydrochlorothiazide; Allopurinol; Prinivil; Betahistine; Amiloride Hydrochloride; Levothyroxine Sodium; Trimetazidine Hydrochloride



Possible Nifedipine side effects in 72 year old female

Reported by a consumer/non-health professional from United States on 2011-12-12

Patient: 72 year old female

Reactions: Malaise, Dyspnoea, Drug Ineffective, Hypotension, Oxygen Saturation Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Letairis
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-19
    End date: 2011-11-28

Nifedipine

Other drugs received by patient: Tobramycin / 00304202 /



Possible Nifedipine side effects in 81 year old male

Reported by a physician from United States on 2011-12-08

Patient: 81 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Encephalopathy, Disorientation

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Sorafenib (Raf Kinase Inhibitor)
    Administration route: Oral
    Start date: 2010-08-27
    End date: 2010-09-29

Sorafenib (Raf Kinase Inhibitor)
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2010-05-14
    End date: 2010-08-23

Nifedipine
    Dosage: 10 mg, qd
    Indication: Hypertension
    Start date: 2009-06-01
    End date: 2010-08-23

Nifedipine
    Dosage: 10 mg (daily dose), qd,

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017